La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Vincent Medical Holdings Gestione
Gestione criteri di controllo 3/4
Vincent Medical Holdings' Il CEO è Raymond Choi, nominato in Jan2023, e ha un mandato di 1.58 anni. la retribuzione annua totale è HK$ 1.52M, composta da 80.8% di stipendio e 19.2% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 1.48% delle azioni della società, per un valore di HK$ 3.83M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.3 anni e 8.2 anni.
Informazioni chiave
Raymond Choi
Amministratore delegato
HK$1.5m
Compenso totale
Percentuale dello stipendio del CEO | 80.8% |
Mandato del CEO | 1.7yrs |
Proprietà del CEO | 1.5% |
Durata media del management | 2.4yrs |
Durata media del Consiglio di amministrazione | 8.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?
Aug 23Investors Met With Slowing Returns on Capital At Vincent Medical Holdings (HKG:1612)
May 21Returns On Capital Are Showing Encouraging Signs At Vincent Medical Holdings (HKG:1612)
Dec 21Vincent Medical Holdings (HKG:1612) Is Experiencing Growth In Returns On Capital
Aug 29Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?
May 30Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?
Dec 15One Analyst Thinks Vincent Medical Holdings Limited's (HKG:1612) Revenues Are Under Threat
Aug 07Vincent Medical Holdings' (HKG:1612) Returns Have Hit A Wall
Aug 06Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025
May 25Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025
Apr 27Vincent Medical Holdings (HKG:1612) Will Pay A Smaller Dividend Than Last Year
Apr 07Under The Bonnet, Vincent Medical Holdings' (HKG:1612) Returns Look Impressive
Mar 08Downgrade: Here's How This Analyst Sees Vincent Medical Holdings Limited (HKG:1612) Performing In The Near Term
Jul 27Is Vincent Medical Holdings (HKG:1612) A Risky Investment?
Jun 06One Vincent Medical Holdings Limited (HKG:1612) Analyst Just Slashed Their Estimates By A Material 13%
Mar 28Vincent Medical Holdings Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Mar 25Vincent Medical Holdings (HKG:1612) Knows How To Allocate Capital
Mar 23Have Insiders Been Buying Vincent Medical Holdings Limited (HKG:1612) Shares This Year?
Mar 04I Ran A Stock Scan For Earnings Growth And Vincent Medical Holdings (HKG:1612) Passed With Ease
Feb 17Is There An Opportunity With Vincent Medical Holdings Limited's (HKG:1612) 42% Undervaluation?
Feb 04What You Need To Know About Vincent Medical Holdings Limited's (HKG:1612) Investor Composition
Jan 22Investors Who Bought Vincent Medical Holdings (HKG:1612) Shares A Year Ago Are Now Up 267%
Jan 08Has Vincent Medical Holdings Limited's (HKG:1612) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 26What We Learned About Vincent Medical Holdings' (HKG:1612) CEO Compensation
Dec 14Did Vincent Medical Holdings Limited (HKG:1612) Insiders Buy Up More Shares?
Dec 02Can Vincent Medical Holdings (HKG:1612) Keep Up These Impressive Returns?
Nov 20Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Jun 30 2024 | n/a | n/a | HK$64m |
Mar 31 2024 | n/a | n/a | HK$61m |
Dec 31 2023 | HK$2m | HK$1m | HK$57m |
Compensazione vs Mercato: La retribuzione totale di Raymond ($USD 194.38K ) è circa la media per le aziende di dimensioni simili nel mercato Hong Kong ($USD 235.63K ).
Compensazione vs guadagni: Dati insufficienti per confrontare la retribuzione di Raymond con le performance aziendali.
AMMINISTRATORE DELEGATO
Raymond Choi (41 yo)
1.7yrs
Mandato
HK$1,515,000
Compensazione
Mr. Cheung Tai Choi, also known as Raymond, served as Deputy Chief Executive Officer of Vincent Medical Holdings Limited since January 1, 2022 until January 1, 2023 and serves as its Chief Executive Office...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Executive Chairman | 8.8yrs | HK$1.49m | 1.68% HK$ 4.3m | |
CEO & Executive Director | 1.7yrs | HK$1.52m | 1.48% HK$ 3.8m | |
VP of OEM Business & Executive Director | no data | HK$1.47m | 0.78% HK$ 2.0m | |
Executive Director | no data | HK$1.42m | 0.93% HK$ 2.4m | |
Chief Financial Officer | no data | Nessun dato | Nessun dato | |
Associate Director of Operations | no data | Nessun dato | Nessun dato | |
Vice President of Sales & Marketing | no data | Nessun dato | Nessun dato | |
Head of Corporate Sustainability & Development | no data | Nessun dato | Nessun dato | |
Head of Sales & Marketing of Greater China | 2.4yrs | Nessun dato | Nessun dato | |
Company Secretary | 7.3yrs | Nessun dato | Nessun dato |
2.4yrs
Durata media
51yo
Età media
Gestione esperta: Il team dirigenziale di 1612 è considerato esperto (durata media dell'incarico 2.3 anni).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Executive Chairman | 8.8yrs | HK$1.49m | 1.68% HK$ 4.3m | |
CEO & Executive Director | 1.7yrs | HK$1.52m | 1.48% HK$ 3.8m | |
VP of OEM Business & Executive Director | 8.5yrs | HK$1.47m | 0.78% HK$ 2.0m | |
Executive Director | 8.5yrs | HK$1.42m | 0.93% HK$ 2.4m | |
Independent Non-Executive Director | 8.3yrs | HK$240.00k | Nessun dato | |
Independent Non-Executive Director | 8.3yrs | HK$276.00k | Nessun dato | |
Independent Non-Executive Director | 7.6yrs | HK$264.00k | Nessun dato | |
Non Executive Director | 1.2yrs | HK$99.00k | Nessun dato |
8.3yrs
Durata media
65yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 1612 sono considerati esperti (durata media dell'incarico 8.2 anni).